COVID-19 Exposes Health Inequities
COVID-19 has had a disproportionate impact on Black and Latino Americans, as well as members of other minority groups.
Progress Against Cancer
COVID-19 has had a disproportionate impact on Black and Latino Americans, as well as members of other minority groups.
Communication gaps can shift extra burden to parents.
The AACR NextGen Grants for Transformative Cancer Research support early-career investigators who are pursuing highly innovative cancer research projects that have the potential to transform the field’s understanding of cancer development and/or treatment.
The FDA approved the use of an immune checkpoint inhibitor to treat certain patients with cutaneous squamous cell carcinoma.
The FDA has approved a targeted therapy drug to treat certain adult patients with diffuse large B-cell lymphoma.
A study indicates that a sedentary lifestyle increases risk of death from cancer, and more news of the week from Cancer Today.
Geriatric assessment improves quality of life in older adults with cancer.
The FDA approved the use of a companion diagnostic to identify patients with tumors that have large numbers of genetic mutations.
Identifying people at the highest risk for pancreatic cancer could better identify those who should be screened to catch the disease sooner.
The FDA approved an analog of a marine compound to treat certain patients with small cell lung cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More